Report: Strong growth for Argentina's pharma industry

04/29/2013 | PharmaTimes (U.K.)

With strong domestic manufacturers, high-quality production standards and an attractive clinical-trial environment, Argentina's pharmaceutical industry should grow rapidly from $5.6 billion in 2012 to an estimated $15 billion by 2020, according to the research firm GlobalData. Domestic manufacturers such as Roemmers and Bago account for half of the nation's drug market, although multinationals such as Abbott, Bayer, GlaxoSmithKline, Novartis and Roche are active as well. Argentina faces challenges from large-scale production facilities in India and China, GlobalData said, and has not yet proven able to innovate and develop New Chemical Entities.

View Full Article in:

PharmaTimes (U.K.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Payer Marketing
Avalere Health
Washington, DC
Chief Quality Officer
UnityPoint Clinic
Des Moines, ID
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX
The Pew Charitable Trusts
Director, Antibiotics and Innovation Project
Washington, DC
Senior Officer, Drugs and Medical Devices
The Pew Charitable Trusts
Washington, DC